Journal Article Summary
This article investigates how the medication nintedanib, used to treat systemic sclerosis-associated interstitial lung disease (SSc-ILD), affects the levels of the oral contraceptive Microgynon, which contains ethinylestradiol and levonorgestrel. Understanding this interaction is crucial because nintedanib can cause harm to a developing fetus, making it important for women of childbearing age to use effective contraception while on this medication. The study aims to ensure that the contraceptive remains effective when taken alongside nintedanib.
The study involved 17 female patients with SSc-ILD, and pharmacokinetic data from 15 of these patients were analyzed. Participants took Microgynon alone and then again after being treated with nintedanib for at least ten days. The results showed that the overall exposure to ethinylestradiol was not significantly affected by nintedanib, while there was a slight increase in its peak concentration. In contrast, the total exposure to levonorgestrel decreased slightly when taken with nintedanib, but this finding should be interpreted cautiously due to limitations in the data collection.
Limitations of the study include a small sample size and the potential for variability in pharmacokinetic data due to the short sampling period. Patients should discuss any concerns about drug interactions and contraceptive effectiveness with their healthcare providers, especially if they are taking nintedanib and using hormonal contraception. Overall, the study suggests that nintedanib does not significantly impact the effectiveness of Microgynon, but ongoing communication with healthcare professionals is essential for safe medication management.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Vonk Madelon C., Guillén-Del-Castillo Alfredo, Kreuter Michael, Avis Mandy, Marzin Kristell, Mack Salome R., Wind Sven, Gahlemann Martina. A Drug–Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Microgynon (Ethinylestradiol and Levonorgestrel) in Female Patients with Systemic Sclerosis-Associated Interstitial Lung Disease. European Journal of Drug Metabolism and Pharmacokinetics 2021. DOI: 10.1007/s13318-021-00728-7. PMID: 34664183. PMCID: PMC8752527.
Featured Pill Pals Product
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill --- Lupin Pharma
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
